EA201291463A1 - Составы для инфузии лантибиотиков типа b - Google Patents
Составы для инфузии лантибиотиков типа bInfo
- Publication number
- EA201291463A1 EA201291463A1 EA201291463A EA201291463A EA201291463A1 EA 201291463 A1 EA201291463 A1 EA 201291463A1 EA 201291463 A EA201291463 A EA 201291463A EA 201291463 A EA201291463 A EA 201291463A EA 201291463 A1 EA201291463 A1 EA 201291463A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lantibiotic
- infantion
- compositions
- type
- infusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Предложен жидкий коллоидный фармацевтический состав лантибиотика типа В для инфузии или прямой инъекции, содержащий лантибиотик типа В или его соль, изотонический водный раствор, содержащий сахарный спирт, такой как глицерин и/или сахарид, и, возможно, буфер, при этом указанный готовый состав для инфузии или прямой инъекции не содержит видимых частиц.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1013513.5A GB201013513D0 (en) | 2010-08-11 | 2010-08-11 | Formulations |
PCT/GB2011/001191 WO2012020219A2 (en) | 2010-08-11 | 2011-08-09 | Formulations for infusion of type b lantibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201291463A1 true EA201291463A1 (ru) | 2013-07-30 |
EA024344B1 EA024344B1 (ru) | 2016-09-30 |
Family
ID=42931511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201291463A EA024344B1 (ru) | 2010-08-11 | 2011-08-09 | Составы для инфузии лантибиотиков типа b |
Country Status (9)
Country | Link |
---|---|
US (1) | US9192569B2 (ru) |
EP (1) | EP2603204A2 (ru) |
JP (1) | JP5865374B2 (ru) |
CN (1) | CN103108628B (ru) |
CA (1) | CA2807206A1 (ru) |
EA (1) | EA024344B1 (ru) |
GB (1) | GB201013513D0 (ru) |
MX (1) | MX2013001470A (ru) |
WO (1) | WO2012020219A2 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3464336T (lt) | 2016-06-01 | 2022-05-10 | Athira Pharma, Inc. | Junginiai |
CA3073806A1 (en) | 2017-09-11 | 2019-03-14 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
CN109620979B (zh) * | 2018-12-29 | 2020-09-01 | 福建师范大学 | 低离子休克提高氨基糖苷类抗生素杀灭持留菌效率的方法 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1013513A (en) | 1963-03-25 | 1965-12-15 | Watney Combe Reid & Co Ltd | Improvements in and relating to hopping beer |
US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
GB8507528D0 (en) | 1985-03-22 | 1985-05-01 | Lepetit Spa | Basis monocarboxyamide derivatives |
US5304540A (en) | 1988-06-22 | 1994-04-19 | Applied Microbiology, Inc. | Pharmaceutical bacteriocin compositions and methods for using the same |
IN167138B (ru) | 1988-08-17 | 1990-09-01 | Hoechst India | |
GB8926639D0 (en) | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
IL107887A (en) | 1992-12-08 | 2003-07-06 | Ambi Inc | Stabilized lanthionine containing bacteriocin compositions |
US5512269A (en) * | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
PT700998E (pt) | 1994-09-12 | 2004-03-31 | Aventis Pharma Gmbh | Mersacidina recombinante e metodo para a sua producao |
US5866539A (en) | 1995-06-23 | 1999-02-02 | Ambi Inc. | Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US5985823A (en) | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
US5958873A (en) | 1997-06-09 | 1999-09-28 | University Of Cincinnati | Oral formulation for treatment of bacteria-induced diseases of the colon |
DE19745583A1 (de) | 1997-10-15 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben |
US6569830B1 (en) | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
CZ303572B6 (cs) | 2000-06-28 | 2012-12-12 | Smithkline Beecham P. L. C. | Jemne rozmelnený prostredek a zpusob jeho prípravy |
SK862003A3 (en) | 2000-06-28 | 2003-06-03 | Teva Pharma | Carvedilol |
GB0110432D0 (en) | 2001-04-27 | 2001-06-20 | Plant Bioscience Ltd | Lantibiotic production |
WO2002103010A1 (en) | 2001-06-14 | 2002-12-27 | Plant Bioscience Limited | Methods and materials for targeted gene disruption in actinomycete bacteria |
US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
CA2501855A1 (en) | 2002-10-10 | 2004-04-22 | Molichem Medicines, Inc. | Nucleic acids encoding duramycin |
WO2004037167A2 (en) * | 2002-10-18 | 2004-05-06 | Molichem Medicines, Inc. | Methods of treating dry eye disease with lantibiotics |
JP4163737B2 (ja) | 2003-07-18 | 2008-10-08 | ヴァイキュロン ファーマシューティカルズ, インコーポレイテッド | 抗生物質107891、そのa1因子とa2因子、その薬剤学的に許容される塩、組成物、およびその使用 |
US7351687B2 (en) | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
CA2554537A1 (en) | 2004-02-17 | 2005-09-01 | Cancervax Corporation | Method and composition for angiogenesis inhibition |
GB0406870D0 (en) | 2004-03-26 | 2004-04-28 | Novacta Biosystems Ltd | Improvements relating to the production of lantibiotics |
CA2623624A1 (en) | 2005-09-27 | 2007-04-05 | Novacta Biosystems Limited | Variants of the lantibiotic mersacidin and their use |
GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
EP2078042B1 (en) | 2006-10-27 | 2019-06-12 | Capsugel Belgium NV | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
CA2690267A1 (en) | 2007-06-12 | 2008-12-18 | The University Of British Columbia | Small cationic antimicrobial peptides |
GB0714029D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
GB0714030D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
RU2506272C2 (ru) | 2008-11-24 | 2014-02-10 | Сентинелла Фармасьютикалз, Инк. ("Сентинелла") | Лантибиотические карбоксиамидные производные с усиленной антибактериальной активностью |
GB0900599D0 (en) | 2009-01-14 | 2009-02-18 | Novacta Biosystems Ltd | Treatment |
EA021683B1 (ru) * | 2009-01-14 | 2015-08-31 | Новакта Биосистемс Лимитед | Производные деоксиактагардина в |
SG173504A1 (en) * | 2009-02-04 | 2011-09-29 | Novacta Biosystems Ltd | Actagardine derivatives |
JP5852966B2 (ja) | 2010-02-02 | 2016-02-03 | ノヴァクタ バイオシステムズ リミティッド | ランチビオティックの塩 |
GB201001688D0 (en) | 2010-02-02 | 2010-03-17 | Novacta Biosystems Ltd | Compounds |
JP2013531026A (ja) | 2010-07-14 | 2013-08-01 | ノヴァクタ バイオシステムズ リミティッド | B型ランチビオティックを含む製剤 |
-
2010
- 2010-08-11 GB GBGB1013513.5A patent/GB201013513D0/en not_active Ceased
-
2011
- 2011-08-09 EA EA201291463A patent/EA024344B1/ru not_active IP Right Cessation
- 2011-08-09 MX MX2013001470A patent/MX2013001470A/es not_active Application Discontinuation
- 2011-08-09 EP EP11749878.2A patent/EP2603204A2/en not_active Withdrawn
- 2011-08-09 WO PCT/GB2011/001191 patent/WO2012020219A2/en active Application Filing
- 2011-08-09 JP JP2013523659A patent/JP5865374B2/ja not_active Expired - Fee Related
- 2011-08-09 US US13/816,063 patent/US9192569B2/en not_active Expired - Fee Related
- 2011-08-09 CN CN201180038723.5A patent/CN103108628B/zh not_active Expired - Fee Related
- 2011-08-09 CA CA2807206A patent/CA2807206A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5865374B2 (ja) | 2016-02-17 |
US20130137630A1 (en) | 2013-05-30 |
EA024344B1 (ru) | 2016-09-30 |
JP2013533304A (ja) | 2013-08-22 |
CA2807206A1 (en) | 2012-02-16 |
CN103108628B (zh) | 2015-08-05 |
CN103108628A (zh) | 2013-05-15 |
EP2603204A2 (en) | 2013-06-19 |
US9192569B2 (en) | 2015-11-24 |
GB201013513D0 (en) | 2010-09-22 |
WO2012020219A3 (en) | 2012-04-05 |
MX2013001470A (es) | 2013-05-14 |
WO2012020219A2 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502778B1 (en) | Antibody formulation | |
EA201490815A1 (ru) | Составы этанерцепта, стабилизированные с помощью аминокислот | |
EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201201659A1 (ru) | Водная композиция, содержащая бромгексин | |
EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201501032A1 (ru) | Фармацевтическая композиция, способы лечения и ее применения | |
MY156188A (en) | Long - acting formulations of insulins | |
PH12015500850A1 (en) | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | |
CL2014001345A1 (es) | Metodos de tratamiento usando un anticuerpo contra interferon gamma; usos composicion farmaceutica que contiene un anticuerpo contra interferon gamma. | |
BR112013026883A2 (pt) | Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica | |
BR112016008576A2 (pt) | Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
WO2014199352A3 (en) | Lipid-based platinum-n-heterocyclic carbene compounds and nanoparticles | |
AR098168A1 (es) | Formulación estable de insulina glulisina | |
PH12014502352A1 (en) | Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition | |
PE20150190A1 (es) | Formulacion farmaceutica | |
UA117480C2 (uk) | Лікування цукрового діабету за допомогою складу інсуліну тривалої дії | |
EA201391729A1 (ru) | Состав, содержащий антитело | |
EA201390467A1 (ru) | Композиции антител и способы применения | |
PH12015500704A1 (en) | Pharmaceutical composition comprising rebamipide | |
EA201291463A1 (ru) | Составы для инфузии лантибиотиков типа b | |
MX2014009660A (es) | Formulacion de anticuerpo anti-selectina p. | |
MX359106B (es) | Composicion farmaceutica inyectable de dexketoprofeno y tramadol. | |
EA201590452A1 (ru) | СОЛИ СОЕДИНЕНИЯ БЕНЗОТИАЗОЛОНА В КАЧЕСТВЕ АГОНИСТОВ β-2-АДРЕНОРЕЦЕПТОРОВ | |
RU2011127039A (ru) | Алкогольный напиток |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |